Inflammatory pre-conditioning of mesenchymal multipotent stromal cells improves their immunomodulatory potency in acute pyelonephritis in rats

Cytotherapy

Volumn 15, Issue 6, 2013, Pages 679-689

  Plotnikov, Egor Y ^a   Pulkova, Natalya V ^a   Pevzner, Irina B ^a   Zorova, Ljubava D ^a   Silachev, Denis N ^a   Morosanova, Maria A ^a   Sukhikh, Gennady T ^b   Zorov, Dmitry B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

cytokines; inflammation; preconditioning; stem cells

Indexed keywords

GELATINASE A; GLYCOGEN SYNTHASE KINASE 3BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PYELONEPHRITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD ANALYSIS; CELL THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; IMMUNOMODULATION; IN VIVO STUDY; LEUKOCYTE; MESENCHYMAL STROMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; CELL COMMUNICATION; CYTOKINES; HUMANS; IMMUNOMODULATION; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PYELONEPHRITIS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877582796     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.02.003     Document Type: Article

References (51)

1. B. Foxman Epidemiology of urinary tract infections: incidence, morbidity, and economic costs Dis Mon 49 2003 53 70
2. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection Pediatrics 103 1999 843 852
3. B. Jakobsson, and L. Svensson Transient pyelonephritic changes on 99mTechnetium-dimercaptosuccinic acid scan for at least five months after infection Acta Paediatr 86 1997 803 807
4. K. Pistor, K. Scharer, H. Olbing, and T. Tamminen-Möbius Children with chronic renal failure in the Federal Republic of Germany: II. Primary renal diseases, age and intervals from early renal failure to renal death. Arbeitsgemeinschaft fur Padiatrische Nephrologie Clin Nephrol 23 1985 278 284
5. G.M. Nassar, and K.F. Badr Novel approaches to treatment of glomerulonephritis J Nephrol 11 1998 177 184
6. Guidelines for the management of acute urinary tract infection in childhood. Report of a Working Group of the Research Unit, Royal College of Physicians J R Coll Physicians Lond 25 1991 36 42
7. R. Gupta, I. Verma, S. Sharma, and N.K. Ganguly Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis - role of free radical scavengers Comp Immunol Microbiol Infect Dis 27 2004 225 234
8. A. Gupta, N. Sharma, B.K. Sharma, S. Sharma, and N.K. Ganguly Oxygen-dependent and -independent mechanisms of renal injury in experimental ascending pyelonephritis FEMS Immunol Med Microbiol 13 1996 35 42
9. H. Mundi, B. Bjorksten, C. Svanborg, L. Ohman, and C. Dahlgren Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring Infect Immun 59 1991 4168 4172
10. K.F. Badr Glomerulonephritis: roles for lipoxygenase pathways in pathophysiology and therapy Curr Opin Nephrol Hypertens 6 1997 111 118
11. A. Uccelli, L. Moretta, and V. Pistoia Immunoregulatory function of mesenchymal stem cells Eur J Immunol 36 2006 2566 2573
12. D.J. Prockop, D.J. Kota, N. Bazhanov, and R.L. Reger Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) J Cell Mol Med 14 2010 2190 2199
13. I. Rasmusson Immune modulation by mesenchymal stem cells Exp Cell Res 312 2006 2169 2179
14. M. Shi, Z.W. Liu, and F.S. Wang Immunomodulatory properties and therapeutic application of mesenchymal stem cells Clin Exp Immunol 164 2011 1 8
15. K. Nemeth, A. Leelahavanichkul, P.S. Yuen, B. Mayer, A. Parmelee, and K. Doi Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat Med 15 2009 42 49
16. M.E. Reinders, W.E. Fibbe, and T.J. Rabelink Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation Nephrol Dial Transplant 25 2010 17 24
17. V.I. Kirpatovskii, A.V. Kazachenko, E.Y. Plotnikov, M.V. Marei, R.A. Musina, and O.N. Nadtochii Experimental intravenous cell therapy of acute and chronic renal failure Bull Exp Biol Med 143 2007 160 165
18. K. Le Blanc, I. Rasmusson, B. Sundberg, C. Götherström, M. Hassan, and M. Uzunel Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441
19. N. Gupta, X. Su, B. Popov, J.W. Lee, V. Serikov, and MA. Matthay Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice J Immunol 179 2007 1855 1863
20. H. Ohtaki, J.H. Ylostalo, J.E. Foraker, A.P. Robinson, R.L. Reger, and S. Shioda Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses Proc Natl Acad Sci U S A 105 2008 14638 14643
21. J.A. Lee, B.I. Kim, C.H. Jo, C.W. Choi, E.K. Kim, and H.S. Kim Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model Pediatr Res 67 2010 42 46
22. M. Mihara, and M. Uchiyama Determination of malonaldehyde precursor in tissues by thiobarbituric acid test Anal Biochem 86 1978 271 278
23. C. Schierwagen, A.C. Bylund-Fellenius, and C. Lundberg Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity J Pharmacol Methods 23 1990 179 186
24. A.G. Basnakian, G.P. Kaushal, and S.V. Shah Apoptotic pathways of oxidative damage to renal tubular epithelial cells Antioxid Redox Signal 4 2002 915 924
25. S.J. Weiss Tissue destruction by neutrophils N Engl J Med 320 1989 365 376
26. H.F. Goode, H.C. Cowley, B.E. Walker, P.D. Howdle, and N.R. Webster Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction Crit Care Med 23 1995 646 651
27. J.L. Vinas, A. Sola, and G. Hotter Mitochondrial NOS upregulation during renal I/R causes apoptosis in a peroxynitrite-dependent manner Kidney Int 69 2006 1403 1409
28. X. Fu, B. Han, S. Cai, Y. Lei, T. Sun, and Z. Sheng Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing Wound Repair Regen 17 2009 185 191
29. M.B. Herrera, B. Bussolati, S. Bruno, L. Morando, G. Mauriello-Romanazzi, and F. Sanavio Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury Kidney Int 72 2007 430 441
30. A.L. Ponte, E. Marais, N. Gallay, A. Langonné, B. Delorme, and O. Hérault The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities Stem Cells 25 2007 1737 1745
31. N.J. Webb, and P.E. Brenchley Cytokines and cell adhesion molecules in the inflammatory response during acute pyelonephritis Nephron Exp Nephrol 96 2004 e1 e6
32. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, and K.W. Fishbein Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 2004 1535 1549
33. E.Y. Plotnikov, A.V. Kazachenko, M.Y. Vyssokikh, A.K. Vasileva, D.V. Tcvirkun, and N.K. Isaev The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney Kidney Int 72 2007 1493 1502
34. K.W. Liechty, T.C. MacKenzie, A.F. Shaaban, A. Radu, A.M. Moseley, and R. Deans Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep Nat Med 6 2000 1282 1286
35. M. Haraoka, T. Matsumoto, K. Takahashi, S. Kubo, M. Tanaka, and J. Kumazawa Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats J Urol 151 1994 1078 1080
36. R.T. Bennett, R.J. Mazzaccaro, N. Chopra, A. Melman, and I. Franco Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats J Urol 161 1999 1681 1684
37. M. Imamoglu, A. Cay, U. Cobanoglu, E. Bahat, C. Karahan, and I. Tosun Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis Urology 67 2006 1315 1319
38. J.A. Roberts, M.B. Kaack, and G. Baskin Treatment of experimental pyelonephritis in the monkey J Urol 143 1990 150 154
39. T. Matsumoto, Y. Mitzunoe, N. Ogata, M. Tanaka, K. Takahashi, and J. Kumazawa Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria Nephron 60 1992 210 215
40. R. Medzhitov, D.S. Schneider, and M.P. Soares Disease tolerance as a defense strategy Science 335 2012 936 941
41. J. Liang, H. Zhang, B. Hua, H. Wang, L. Lu, and S. Shi Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study Ann Rheum Dis 69 2010 1423 1429
42. J.M. Fox, G. Chamberlain, B.A. Ashton, and J. Middleton Recent advances into the understanding of mesenchymal stem cell trafficking Br J Haematol 137 2007 491 502
43. K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, and T. Nagai Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells Blood 109 2007 228 234
44. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, and P. Matteucci Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
45. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621
46. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
47. A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, and M. De Waele Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 Haematologica 92 2007 440 449
48. C. Steingen, F. Brenig, L. Baumgartner, J. Schmidt, A. Schmidt, and W. Bloch Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells J Mol Cell Cardiol 44 2008 1072 1084
49. K.H. Ko, T. Holmes, P. Palladinetti, E. Song, R. Nordon, and T.A. O'Brien GSK-3beta inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression Stem Cells 29 2011 108 118
50. J.J. Trowbridge, A. Xenocostas, R.T. Moon, and M. Bhatia Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation Nat Med 12 2006 89 98
51. L.K. Tsai, Z. Wang, J. Munasinghe, Y. Leng, P. Leeds, and D.M. Chuang Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model Stroke 42 2011 2932 2939